PortfoliosLab logo
ARKF vs. ARKG
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ARKF and ARKG is 0.62, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

ARKF vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ARK Fintech Innovation ETF (ARKF) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%NovemberDecember2025FebruaryMarchApril
79.79%
-18.06%
ARKF
ARKG

Key characteristics

Sharpe Ratio

ARKF:

0.76

ARKG:

-0.14

Sortino Ratio

ARKF:

1.25

ARKG:

0.11

Omega Ratio

ARKF:

1.16

ARKG:

1.01

Calmar Ratio

ARKF:

0.45

ARKG:

-0.08

Martin Ratio

ARKF:

2.63

ARKG:

-0.49

Ulcer Index

ARKF:

10.66%

ARKG:

13.33%

Daily Std Dev

ARKF:

37.13%

ARKG:

45.73%

Max Drawdown

ARKF:

-78.63%

ARKG:

-83.59%

Current Drawdown

ARKF:

-43.25%

ARKG:

-79.96%

Returns By Period

In the year-to-date period, ARKF achieves a -2.59% return, which is significantly higher than ARKG's -4.86% return.


ARKF

YTD

-2.59%

1M

2.27%

6M

15.23%

1Y

29.40%

5Y*

8.71%

10Y*

N/A

ARKG

YTD

-4.86%

1M

0.72%

6M

-3.86%

1Y

-3.36%

5Y*

-11.56%

10Y*

0.53%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ARKF vs. ARKG - Expense Ratio Comparison

Both ARKF and ARKG have an expense ratio of 0.75%.


Expense ratio chart for ARKF: current value is 0.75%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
ARKF: 0.75%
Expense ratio chart for ARKG: current value is 0.75%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
ARKG: 0.75%

Risk-Adjusted Performance

ARKF vs. ARKG — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ARKF
The Risk-Adjusted Performance Rank of ARKF is 7070
Overall Rank
The Sharpe Ratio Rank of ARKF is 7373
Sharpe Ratio Rank
The Sortino Ratio Rank of ARKF is 7575
Sortino Ratio Rank
The Omega Ratio Rank of ARKF is 7373
Omega Ratio Rank
The Calmar Ratio Rank of ARKF is 5959
Calmar Ratio Rank
The Martin Ratio Rank of ARKF is 6969
Martin Ratio Rank

ARKG
The Risk-Adjusted Performance Rank of ARKG is 1717
Overall Rank
The Sharpe Ratio Rank of ARKG is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of ARKG is 2020
Sortino Ratio Rank
The Omega Ratio Rank of ARKG is 1919
Omega Ratio Rank
The Calmar Ratio Rank of ARKG is 1616
Calmar Ratio Rank
The Martin Ratio Rank of ARKG is 1212
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ARKF vs. ARKG - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ARK Fintech Innovation ETF (ARKF) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for ARKF, currently valued at 0.76, compared to the broader market-1.000.001.002.003.004.00
ARKF: 0.76
ARKG: -0.14
The chart of Sortino ratio for ARKF, currently valued at 1.25, compared to the broader market-2.000.002.004.006.008.00
ARKF: 1.25
ARKG: 0.11
The chart of Omega ratio for ARKF, currently valued at 1.16, compared to the broader market0.501.001.502.00
ARKF: 1.16
ARKG: 1.01
The chart of Calmar ratio for ARKF, currently valued at 0.45, compared to the broader market0.002.004.006.008.0010.0012.00
ARKF: 0.45
ARKG: -0.08
The chart of Martin ratio for ARKF, currently valued at 2.63, compared to the broader market0.0020.0040.0060.00
ARKF: 2.63
ARKG: -0.49

The current ARKF Sharpe Ratio is 0.76, which is higher than the ARKG Sharpe Ratio of -0.14. The chart below compares the historical Sharpe Ratios of ARKF and ARKG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.76
-0.14
ARKF
ARKG

Dividends

ARKF vs. ARKG - Dividend Comparison

Neither ARKF nor ARKG has paid dividends to shareholders.


TTM20242023202220212020201920182017
ARKF
ARK Fintech Innovation ETF
0.00%0.00%0.00%0.00%0.00%0.37%1.25%0.00%0.00%
ARKG
ARK Genomic Revolution Multi-Sector ETF
0.00%0.00%0.00%0.00%0.62%0.85%3.14%1.94%1.34%

Drawdowns

ARKF vs. ARKG - Drawdown Comparison

The maximum ARKF drawdown since its inception was -78.63%, smaller than the maximum ARKG drawdown of -83.59%. Use the drawdown chart below to compare losses from any high point for ARKF and ARKG. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%NovemberDecember2025FebruaryMarchApril
-43.25%
-79.96%
ARKF
ARKG

Volatility

ARKF vs. ARKG - Volatility Comparison

ARK Fintech Innovation ETF (ARKF) and ARK Genomic Revolution Multi-Sector ETF (ARKG) have volatilities of 20.62% and 20.18%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
20.62%
20.18%
ARKF
ARKG